The Motley Fool

If I Could Buy Just One Stock For Christmas, It’d Be GlaxoSmithKline plc

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

It has to be said, I’ve never been one to crave the “next big gadget”, or to follow the crowd when it comes to following particular trends.  But if I was to buy myself a stock as a long-overdue Christmas present to myself, I struggle to look further than one of the most popular among Fools and other investors alike – GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US).

Yes, as it’s a gift to myself I could have speculated a little and moved for a slightly sexier small-cap growth stock, but there’s one thing that the pharma giant can offer my portfolio that most of my other holdings can’t: a great dividend.  Since 2009, the dividend yield has hovered somewhere between 4.6% and 5.5%, with last year’s coming in at a very respectable 4.8%.

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic… and with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. And if you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio.

Click here to claim your free copy now!

Now could be a good time to buy, too, in terms of the share price.  It may have seen a steady rise to just under 1,500 since its October low of 1,324, but overall, the price is still down nearly 6% over the last 6 months.  I could even consider that to be an early January bargain.

One Killer Stock For The Cybersecurity Surge

Cybersecurity is surging, with experts predicting that the cybersecurity market will reach US$366 billion by 2028more than double what it is today!

And with that kind of growth, this North American company stands to be the biggest winner.

Because their patented “self-repairing” technology is changing the cybersecurity landscape as we know it…

We think it has the potential to become the next famous tech success story.

In fact, we think it could become as big… or even BIGGER than Shopify.

Click here to see how you can uncover the name of this North American stock that’s taking over Silicon Valley, one device at a time…

Chris Nials has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.